Adverse Effects

The principal adverse effect associated with throm-bolytic therapy is bleeding due to fibrinogenolysis or fibrinolysis at the site of vascular injury. Hypo-fibrinogenemia may occur and should be monitored with laboratory tests. At effective thrombolytic doses, the second- and third-generation agents cause less extensive fibrinogenolysis, but bleeding occurs with a similar incidence for all agents. Life-threatening intracra-nial bleeding may necessitate stoppage of therapy, administration of whole blood, platelets or fresh frozen plasma, protamine (if heparin is present), and an an-tifibrinolytic drug (discussed later).

The Prevention and Treatment of Headaches

The Prevention and Treatment of Headaches

Are Constant Headaches Making Your Life Stressful? Discover Proven Methods For Eliminating Even The Most Powerful Of Headaches, It’s Easier Than You Think… Stop Chronic Migraine Pain and Tension Headaches From Destroying Your Life… Proven steps anyone can take to overcome even the worst chronic head pain…

Get My Free Audio Book


Post a comment